What question did this study set out to answer?

This research examines the expression of TBC1D16 in hepatocellular carcinoma and its implications for prognosis and diagnosis.

February 14, 2026

The expression pattern and clinical implications of TBC1D16 in hepatocellular carcinoma

Key Points

This research examines the expression of TBC1D16 in hepatocellular carcinoma and its implications for prognosis and diagnosis.
Analyzed TBC1D16 expression levels in hepatocellular carcinoma samples
Investigated the impact of TBC1D16 silencing on NF-κB signaling
Evaluated correlations between TBC1D16 levels and clinical outcomes
Upregulation of TBC1D16 is associated with poor prognosis in HCC patients
Silencing TBC1D16 results in the activation of NF-κB signaling
Higher TBC1D16 expression correlates with increased tumor invasiveness

Abstract

TBC1D16 upregulation in HCC is linked to poor prognosis and enhances tumor invasiveness, silencing TBC1D16 activates NF-κB signaling, indicating its potential role in HCC diagnosis.

Bookmark

The expression pattern and clinical implications of TBC1D16 in hepatocellular carcinoma

Key Points

Abstract

Cite This Study

Also Consider

Also Consider